|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.7 GBX | +4.58% |
|
+4.58% | +51.38% |
| May. 01 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
| May. 01 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
Poolbeg Pharma PLC announces a change to its Board of Directors. Patrick Ashe, Independent Non-Executive Director, will step down from the Board at the end of November. Patrick played a significant role in guiding the Company through its initial phase of development.
Eddie Gibson, Non-Executive Director will replace Patrick as Chair of the Audit & Risk Committee and Prof Brendan Buckley, Non-Executive Director will become Chair of the Remuneration Committee.
| 1st Jan change | Capi. | |
|---|---|---|
| +51.38% | 87.16M | |
| +11.91% | 118B | |
| +11.60% | 106B | |
| -4.68% | 24.28B | |
| -0.82% | 21.96B | |
| -10.12% | 18.16B | |
| -42.12% | 16.37B | |
| -17.47% | 15.56B | |
| +2.77% | 13.63B | |
| +34.58% | 12.27B |
POOLBEG PHARMA PLC 
